{"id":"W3197049258","doi":"10.1182/bloodadvances.2020003534","title":"Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"University of Oxford; University of Bristol; National Institute for Health and Care Research","keywords":"CD19; Minimal residual disease; CD34; Medicine; Leukemia; Immunology; Cancer research; Transplantation; Stem cell; Antigen; Oncology; Internal medicine; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000298399,0.0002485189,0.0004371494,0.0001158918,0.0001817453,0.00006474006,0.0001467864,0.00007691354,0.00123674],"category_scores_gemma":[0.00009647731,0.000188841,0.0000988659,0.0007887679,0.00008428046,0.0002177574,0.00005806608,0.000409446,0.00004118406],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005116881,"about_ca_system_score_gemma":0.0005304905,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001891827,"about_ca_topic_score_gemma":0.000004404858,"domain_scores_codex":[0.9978205,0.00009730504,0.0003135806,0.0005434518,0.0006530341,0.0005721155],"domain_scores_gemma":[0.9988152,0.0001912649,0.0001289133,0.0003950118,0.0002981493,0.0001714259],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001354103,0.0002441418,0.106606,0.0001871453,0.00009397449,0.0005673089,0.0001609635,0.000256377,0.8794266,0.00001017627,0.0000856621,0.01222618],"study_design_scores_gemma":[0.004876037,0.0006708011,0.004967663,0.0001216626,0.0001175948,0.0002346155,0.0006738484,0.0001797612,0.9642752,0.00003272943,0.0234774,0.0003727282],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9709721,0.02310269,0.0001442091,0.0001993776,0.0001680527,0.000412726,0.000006971878,0.0001309758,0.004862868],"genre_scores_gemma":[0.9462808,0.03435189,0.011122,0.0004149688,0.001771406,0.00003331635,0.00008452959,0.0001153277,0.005825752],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1016384,"threshold_uncertainty_score":0.9996763,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01476344073809838,"score_gpt":0.3032942440092108,"score_spread":0.2885308032711124,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}